Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request, 18022-18023 [2022-06593]

Download as PDF 18022 Federal Register / Vol. 87, No. 60 / Tuesday, March 29, 2022 / Notices Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Monday, May 2, 2022. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. app., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. lotter on DSK11XQN23PROD with NOTICES1 II. Agenda On Thursday, May 12, 2022, the Council meeting will convene at 10:00 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting will begin with an introduction of NAC members, an update on AHRQ activities, and a discussion about new opportunities with AHRQ’s new Director. The agenda will also include discussions about AHRQ and the Patient-Centered Outcomes Research (PCOR) Trust Fund and AHRQ’s role in conducting and supporting health services research, analysis and evaluations focused on understanding the effects of healthcare financing policies. The meeting will adjourn at 3:00 p.m. The meeting is open to the public. For information regarding how to access the meeting as well as other meeting details, including information on how to make a public comment, please go to https://www.ahrq.gov/news/ events/nac/. The final agenda will be VerDate Sep<11>2014 17:01 Mar 28, 2022 Jkt 256001 available on the AHRQ website no later than Thursday, May 5, 2022. Dated: March 23, 2022. Marquita Cullom, Associate Director. [FR Doc. 2022–06527 Filed 3–28–22; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meetings Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of five AHRQ subcommittee meetings. AGENCY: The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will be closed to the public. DATES: See below for dates of meetings: 1. Healthcare Research Training (HCRT) Dates: May 19–20, 23, 2022 July 15, 2022 2. Healthcare Effectiveness and Outcomes Research (HEOR) Date: June 8–9, 2022 3. Healthcare Information Technology Research (HITR) Date: June 9–10, 2022 4. Healthcare Safety and Quality Improvement Research (HSQR) Date: June 15–16, 2022 5. Health System and Value Research (HSVR) Date: June 16–17, 2022 ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: (To obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.) Jenny Griffith, Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 427– 1557. SUPPLEMENTARY INFORMATION: In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ’s Health SUMMARY: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. app. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. Dated: March 23, 2022. Marquita Cullom, Associate Director. [FR Doc. 2022–06525 Filed 3–28–22; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10398 #74 and #76] Medicaid and Children’s Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance related to the ‘‘generic’’ clearance process. Generally, this is an expedited process by which agencies may obtain OMB’s approval of collection of information requests that are ‘‘usually voluntary, low-burden, and uncontroversial collections,’’ do not raise any substantive or policy issues, and do not require policy or methodological review. The process requires the submission of an overarching plan that defines the scope of the individual collections that would fall under its umbrella. On October 23, 2011, OMB approved our initial request to use the generic clearance process under control number 0938–1148 (CMS–10398). It was last approved on April 26, 2021, via the standard PRA process which included the publication of 60- and 30-day Federal Register notices. The scope of the April 2021 umbrella accounts for Medicaid and SUMMARY: E:\FR\FM\29MRN1.SGM 29MRN1 lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 87, No. 60 / Tuesday, March 29, 2022 / Notices CHIP State plan amendments, waivers, demonstrations, and reporting. This Federal Register notice seeks public comment on one or more of our collection of information requests that we believe are generic and fall within the scope of the umbrella. Interested persons are invited to submit comments regarding our burden estimates or any other aspect of this collection of information, including: The necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by April 12, 2022. ADDRESSES: When commenting, please reference the applicable form number (see below) and the OMB control number (0938–1148). To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to http:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: CMS–10398 (#ll)/OMB control number: 0938–1148, Room C4– 26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may access CMS’ website at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Following is a summary of the use and burden associated with the subject information collection(s). More detailed information can be found in the collection’s supporting statement and associated materials (see ADDRESSES). Generic Information Collections 1. Title of Information Collection: Coverage of Routine Patient Cost for VerDate Sep<11>2014 17:01 Mar 28, 2022 Jkt 256001 Items & Services in Qualifying Clinical Trials; Type of Information Collection Request: Revised; Use: Section 210 of the Consolidated Appropriations Act of 2021 amended section 1905(a) of the Social Security Act (the Act) to add a new mandatory benefit at 1905(a)(30). The new benefit mandates coverage of routine patient services and costs furnished in connection with participation by Medicaid beneficiaries in qualifying clinical trials. Routine costs for services provided in connection with participation in a qualifying clinical trial generally include any item or service provided to the individual under the qualifying clinical trial, including any item or service provided to prevent, diagnose, monitor, or treat complications resulting from participation in the qualified clinical trial, to the extent that the provision of such items or services to the individual would otherwise be covered under the state plan or waiver. We propose that States and territories review the preprints completed for a Medicaid beneficiary to receive coverage of routine patient services and costs furnished in connection with participation in qualifying clinical trials. Completion of the preprint pages verifies in the Medicaid state plan that the mandatory clinical trials benefit is being furnished by a state. Completion of the preprint verifies that the requirements of a federally sponsored clinical trial is appropriate for the Medicaid beneficiary. Form Number: CMS–10398 (#74) (OMB control number: 0938–1148); Frequency: Once and on occasion; Affected Public: State, Local, or Tribal Governments; Number of Respondents: 56; Total Annual Responses: 66; Total Annual Hours: 61. (For policy questions regarding this collection contact Myla Adams at 410– 786–8107.) 2. Title of Information Collection: Expressions of interest in the Improving Maternal Health by Reducing Low-Risk Cesarean Delivery Affinity Group; Type of Information Collection Request: New collection of information request; Use: State Medicaid and CHIP agencies are given the opportunity to submit the attached Expression of Interest Form regarding participation in the Improving Maternal Health by Reducing Low-Risk Cesarean Delivery Affinity Group. Information requested will be used to see if each state meets the criteria for participation in the Affinity Group. Criteria for affinity group participation include: • Well-articulated goals for improving low-risk cesarean delivery rates, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 18023 • An understanding of the state’s challenges and opportunities related to low-risk cesarean deliveries, • Access to low-risk cesarean delivery data, including the ability to report the Core Set measure Low-Risk Cesarean Delivery (LRCD–CH), • Identification of a well-rounded state team willing to work about 10 to 15 hours each month (depending on role, project, and team size) on the state quality improvement (QI) project, and • Commitment to action, with support from Medicaid and/or CHIP leadership. Once participating in the Affinity Group, a states will meet monthly virtually for workshops and one-on-one state coaching calls, learning from QI advisors, subject matter experts, and peers in order to test, implement, and assess their data-driven QI change idea. Form Number: CMS–10398 (#76) (OMB control number: 0938–1148); Frequency: Once; Affected Public: State, Local, or Tribal Governments; Number of Respondents: 20; Total Annual Responses: 20; Total Annual Hours: 140. (For policy questions regarding this collection contact Kristen Zycherman at 410–786–6974.) Dated: March 24, 2022. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2022–06593 Filed 3–28–22; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10433 and CMS–276] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow SUMMARY: E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 87, Number 60 (Tuesday, March 29, 2022)]
[Notices]
[Pages 18022-18023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06593]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifiers: CMS-10398 #74 and #76]


Medicaid and Children's Health Insurance Program (CHIP) Generic 
Information Collection Activities: Proposed Collection; Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: On May 28, 2010, the Office of Management and Budget (OMB) 
issued Paperwork Reduction Act (PRA) guidance related to the 
``generic'' clearance process. Generally, this is an expedited process 
by which agencies may obtain OMB's approval of collection of 
information requests that are ``usually voluntary, low-burden, and 
uncontroversial collections,'' do not raise any substantive or policy 
issues, and do not require policy or methodological review. The process 
requires the submission of an overarching plan that defines the scope 
of the individual collections that would fall under its umbrella. On 
October 23, 2011, OMB approved our initial request to use the generic 
clearance process under control number 0938-1148 (CMS-10398). It was 
last approved on April 26, 2021, via the standard PRA process which 
included the publication of 60- and 30-day Federal Register notices. 
The scope of the April 2021 umbrella accounts for Medicaid and

[[Page 18023]]

CHIP State plan amendments, waivers, demonstrations, and reporting. 
This Federal Register notice seeks public comment on one or more of our 
collection of information requests that we believe are generic and fall 
within the scope of the umbrella. Interested persons are invited to 
submit comments regarding our burden estimates or any other aspect of 
this collection of information, including: The necessity and utility of 
the proposed information collection for the proper performance of the 
agency's functions, the accuracy of the estimated burden, ways to 
enhance the quality, utility and clarity of the information to be 
collected, and the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.

DATES: Comments must be received by April 12, 2022.

ADDRESSES: When commenting, please reference the applicable form number 
(see below) and the OMB control number (0938-1148). To be assured 
consideration, comments and recommendations must be submitted in any 
one of the following ways:
    1. Electronically. You may send your comments electronically to 
http://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: CMS-10398 (#__)/OMB 
control number: 0938-1148, Room C4-26-05, 7500 Security Boulevard, 
Baltimore, Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, you may 
access CMS' website at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.

FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION: Following is a summary of the use and burden 
associated with the subject information collection(s). More detailed 
information can be found in the collection's supporting statement and 
associated materials (see ADDRESSES).

Generic Information Collections

    1. Title of Information Collection: Coverage of Routine Patient 
Cost for Items & Services in Qualifying Clinical Trials; Type of 
Information Collection Request: Revised; Use: Section 210 of the 
Consolidated Appropriations Act of 2021 amended section 1905(a) of the 
Social Security Act (the Act) to add a new mandatory benefit at 
1905(a)(30). The new benefit mandates coverage of routine patient 
services and costs furnished in connection with participation by 
Medicaid beneficiaries in qualifying clinical trials. Routine costs for 
services provided in connection with participation in a qualifying 
clinical trial generally include any item or service provided to the 
individual under the qualifying clinical trial, including any item or 
service provided to prevent, diagnose, monitor, or treat complications 
resulting from participation in the qualified clinical trial, to the 
extent that the provision of such items or services to the individual 
would otherwise be covered under the state plan or waiver.
    We propose that States and territories review the preprints 
completed for a Medicaid beneficiary to receive coverage of routine 
patient services and costs furnished in connection with participation 
in qualifying clinical trials. Completion of the preprint pages 
verifies in the Medicaid state plan that the mandatory clinical trials 
benefit is being furnished by a state. Completion of the preprint 
verifies that the requirements of a federally sponsored clinical trial 
is appropriate for the Medicaid beneficiary. Form Number: CMS-10398 
(#74) (OMB control number: 0938-1148); Frequency: Once and on occasion; 
Affected Public: State, Local, or Tribal Governments; Number of 
Respondents: 56; Total Annual Responses: 66; Total Annual Hours: 61. 
(For policy questions regarding this collection contact Myla Adams at 
410-786-8107.)
    2. Title of Information Collection: Expressions of interest in the 
Improving Maternal Health by Reducing Low-Risk Cesarean Delivery 
Affinity Group; Type of Information Collection Request: New collection 
of information request; Use: State Medicaid and CHIP agencies are given 
the opportunity to submit the attached Expression of Interest Form 
regarding participation in the Improving Maternal Health by Reducing 
Low-Risk Cesarean Delivery Affinity Group. Information requested will 
be used to see if each state meets the criteria for participation in 
the Affinity Group. Criteria for affinity group participation include:
     Well-articulated goals for improving low-risk cesarean 
delivery rates,
     An understanding of the state's challenges and 
opportunities related to low-risk cesarean deliveries,
     Access to low-risk cesarean delivery data, including the 
ability to report the Core Set measure Low-Risk Cesarean Delivery 
(LRCD-CH),
     Identification of a well-rounded state team willing to 
work about 10 to 15 hours each month (depending on role, project, and 
team size) on the state quality improvement (QI) project, and
     Commitment to action, with support from Medicaid and/or 
CHIP leadership.
    Once participating in the Affinity Group, a states will meet 
monthly virtually for workshops and one-on-one state coaching calls, 
learning from QI advisors, subject matter experts, and peers in order 
to test, implement, and assess their data-driven QI change idea.
    Form Number: CMS-10398 (#76) (OMB control number: 0938-1148); 
Frequency: Once; Affected Public: State, Local, or Tribal Governments; 
Number of Respondents: 20; Total Annual Responses: 20; Total Annual 
Hours: 140. (For policy questions regarding this collection contact 
Kristen Zycherman at 410-786-6974.)

    Dated: March 24, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and 
Regulatory Affairs.
[FR Doc. 2022-06593 Filed 3-28-22; 8:45 am]
BILLING CODE 4120-01-P